1
|
Graf C, MacMillan EL, Fu E, Harris T, Traboulsee A, Vavasour IM, MacKay AL, Mädler B, Li DKB, Laule C. Intra- and inter-site reproducibility of human brain single-voxel proton MRS at 3 T. NMR IN BIOMEDICINE 2019; 32:e4083. [PMID: 30889311 DOI: 10.1002/nbm.4083] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/04/2018] [Revised: 01/24/2019] [Accepted: 01/28/2019] [Indexed: 06/09/2023]
Abstract
INTRODUCTION Clinical trials that involve participants from multiple sites necessitate standardized and reliable quantitative MRI outcomes to detect significant group differences over time. Metabolite concentrations measured by proton MRS (1 H-MRS) provide valuable information about in vivo metabolism of the central nervous system, but can vary based on the acquisition and quantitation methods used by different MR sites. Therefore, we investigated the intra- and inter-site reproducibility of metabolite concentrations measured by 1 H-MRS on MRI scanners from a single manufacturer across six sites. METHODS Five healthy controls were scanned twice within 24 h at six participating 3 T MR sites with large single-voxel PRESS (TE/TR/NSA = 36 ms/4000 ms/56) and anatomical images for voxel positioning and correction of partial volume relaxation. Absolute metabolite concentrations were calculated relative to the T1 and T2 relaxation corrected signal from water. Intra- and inter-site reproducibility was assessed using Bland-Altman plots and intra- and inter-site coefficient of variation (CoV) as well as intra- and inter-site intra-class correlation coefficient. RESULTS The median intra-site CoVs for the five major metabolite concentrations ([NAA], [tCr], [Glu], [tCho] and [Ins]) were between 2.5 and 5.3%. Inter-site CoVs were also low, with the median CoVs for all metabolites between 3.7 and 6.4%. Metabolite concentrations were robust to small inconsistencies in voxel placement and site was not the driving factor in the variance of the measurement of any metabolite concentration. Between-subject differences accounted for the majority of the concentration variability for creatine, choline and myo-inositol (42-65% of the variance). CONCLUSION A large single-voxel 1 H-MRS acquisition from a single manufacturer's MRI scanner is highly reproducible and reliable for multi-site clinical trials.
Collapse
Affiliation(s)
- Carina Graf
- Physics & Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
- International Collaboration on Repair Discoveries (ICORD), Vancouver, British Columbia, Canada
| | - Erin L MacMillan
- MR Clinical Science, Philips Canada, Markham, Ontario, Canada
- UBC MRI Research Centre, University of British Columbia, Vancouver, British Columbia, Canada
- ImageTech Lab, Simon Fraser University, Surrey, British Columbia, Canada
| | - Eric Fu
- Statistics, University of British Columbia, Vancouver, British Columbia, Canada
| | - Trudy Harris
- UBC MRI Research Centre, University of British Columbia, Vancouver, British Columbia, Canada
- Radiology, University of British Columbia, Vancouver, British Columbia, Canada
| | - Anthony Traboulsee
- Medicine (Neurology), University of British Columbia, Vancouver, British Columbia, Canada
| | - Irene M Vavasour
- UBC MRI Research Centre, University of British Columbia, Vancouver, British Columbia, Canada
- Radiology, University of British Columbia, Vancouver, British Columbia, Canada
| | - Alex L MacKay
- Physics & Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
- UBC MRI Research Centre, University of British Columbia, Vancouver, British Columbia, Canada
- Radiology, University of British Columbia, Vancouver, British Columbia, Canada
| | | | - David K B Li
- UBC MRI Research Centre, University of British Columbia, Vancouver, British Columbia, Canada
- Radiology, University of British Columbia, Vancouver, British Columbia, Canada
- Medicine (Neurology), University of British Columbia, Vancouver, British Columbia, Canada
| | - Cornelia Laule
- Physics & Astronomy, University of British Columbia, Vancouver, British Columbia, Canada
- International Collaboration on Repair Discoveries (ICORD), Vancouver, British Columbia, Canada
- Radiology, University of British Columbia, Vancouver, British Columbia, Canada
- Pathology & Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
| |
Collapse
|
2
|
Gramegna LL, Pisano A, Testa C, Manners DN, D'Angelo R, Boschetti E, Giancola F, Pironi L, Caporali L, Capristo M, Valentino ML, Plazzi G, Casali C, Dotti MT, Cenacchi G, Hirano M, Giordano C, Parchi P, Rinaldi R, De Giorgio R, Lodi R, Carelli V, Tonon C. Cerebral Mitochondrial Microangiopathy Leads to Leukoencephalopathy in Mitochondrial Neurogastrointestinal Encephalopathy. AJNR Am J Neuroradiol 2018; 39:427-434. [PMID: 29348134 DOI: 10.3174/ajnr.a5507] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2017] [Accepted: 10/30/2017] [Indexed: 12/14/2022]
Abstract
BACKGROUND AND PURPOSE Mitochondrial neurogastrointestinal encephalopathy is a rare disorder due to recessive mutations in the thymidine phosphorylase gene, encoding thymidine phosphorylase protein required for mitochondrial DNA replication. Clinical manifestations include gastrointestinal dysmotility and diffuse asymptomatic leukoencephalopathy. This study aimed to elucidate the mechanisms underlying brain leukoencephalopathy in patients with mitochondrial neurogastrointestinal encephalopathy by correlating multimodal neuroradiologic features to postmortem pathology. MATERIALS AND METHODS Seven patients underwent brain MR imaging, including single-voxel proton MR spectroscopy and diffusion imaging. Absolute concentrations of metabolites calculated by acquiring unsuppressed water spectra at multiple TEs, along with diffusion metrics based on the tensor model, were compared with those of healthy controls using unpaired t tests in multiple white matters regions. Brain postmortem histologic, immunohistochemical, and molecular analyses were performed in 1 patient. RESULTS All patients showed bilateral and nearly symmetric cerebral white matter hyperintensities on T2-weighted images, extending to the cerebellar white matter and brain stem in 4. White matter, N-acetylaspartate, creatine, and choline concentrations were significantly reduced compared with those in controls, with a prominent increase in the radial water diffusivity component. At postmortem examination, severe fibrosis of brain vessel smooth muscle was evident, along with mitochondrial DNA replication depletion in brain and vascular smooth-muscle and endothelial cells, without neuronal loss, myelin damage, or gliosis. Prominent periependymal cytochrome C oxidase deficiency was also observed. CONCLUSIONS Vascular functional and histologic alterations account for leukoencephalopathy in mitochondrial neurogastrointestinal encephalopathy. Thymidine toxicity and mitochondrial DNA replication depletion may induce microangiopathy and blood-brain-barrier dysfunction, leading to increased water content in the white matter. Periependymal cytochrome C oxidase deficiency could explain prominent periventricular impairment.
Collapse
Affiliation(s)
- L L Gramegna
- From the Functional MR Unit (L.L.G., C.T., D.N.M., R.L., C.T.).,Departments of Biomedical and Neuromotor Sciences (L.L.G., C.T., D.N.M., L.C., M.C., M.L.V., G.P., G.C., P.P., R.L., V.C., C.T.)
| | - A Pisano
- Departments of Radiology, Oncology, and Pathology (A.P., C.G.)
| | - C Testa
- From the Functional MR Unit (L.L.G., C.T., D.N.M., R.L., C.T.).,Neurology Unit (R.D., R.R.), S.Orsola-Malpighi Hospital, Bologna, Italy.,Departments of Biomedical and Neuromotor Sciences (L.L.G., C.T., D.N.M., L.C., M.C., M.L.V., G.P., G.C., P.P., R.L., V.C., C.T.)
| | - D N Manners
- From the Functional MR Unit (L.L.G., C.T., D.N.M., R.L., C.T.).,Departments of Biomedical and Neuromotor Sciences (L.L.G., C.T., D.N.M., L.C., M.C., M.L.V., G.P., G.C., P.P., R.L., V.C., C.T.)
| | - R D'Angelo
- Neurology Unit (R.D., R.R.), S.Orsola-Malpighi Hospital, Bologna, Italy
| | - E Boschetti
- Surgical and Medical Sciences (E.B., F.G., L.P., R.D.G.), University of Bologna, Bologna, Italy
| | - F Giancola
- Surgical and Medical Sciences (E.B., F.G., L.P., R.D.G.), University of Bologna, Bologna, Italy
| | - L Pironi
- Surgical and Medical Sciences (E.B., F.G., L.P., R.D.G.), University of Bologna, Bologna, Italy
| | - L Caporali
- Departments of Biomedical and Neuromotor Sciences (L.L.G., C.T., D.N.M., L.C., M.C., M.L.V., G.P., G.C., P.P., R.L., V.C., C.T.).,Istituto di Ricovero e Cura a Carattere Scientifico Institute of Neurological Sciences (L.C., M.C., M.L.V., G.P., P.P., V.C.), Bologna, Italy
| | - M Capristo
- Departments of Biomedical and Neuromotor Sciences (L.L.G., C.T., D.N.M., L.C., M.C., M.L.V., G.P., G.C., P.P., R.L., V.C., C.T.).,Istituto di Ricovero e Cura a Carattere Scientifico Institute of Neurological Sciences (L.C., M.C., M.L.V., G.P., P.P., V.C.), Bologna, Italy
| | - M L Valentino
- Departments of Biomedical and Neuromotor Sciences (L.L.G., C.T., D.N.M., L.C., M.C., M.L.V., G.P., G.C., P.P., R.L., V.C., C.T.).,Istituto di Ricovero e Cura a Carattere Scientifico Institute of Neurological Sciences (L.C., M.C., M.L.V., G.P., P.P., V.C.), Bologna, Italy
| | - G Plazzi
- Departments of Biomedical and Neuromotor Sciences (L.L.G., C.T., D.N.M., L.C., M.C., M.L.V., G.P., G.C., P.P., R.L., V.C., C.T.).,Istituto di Ricovero e Cura a Carattere Scientifico Institute of Neurological Sciences (L.C., M.C., M.L.V., G.P., P.P., V.C.), Bologna, Italy
| | - C Casali
- Medico-Surgical Sciences and Biotechnologies (C.C.), Sapienza, University of Rome, Rome, Italy
| | - M T Dotti
- Department of Medicine, Surgery, and Neuroscience (M.T.D.), University of Siena, Siena, Italy
| | - G Cenacchi
- Departments of Biomedical and Neuromotor Sciences (L.L.G., C.T., D.N.M., L.C., M.C., M.L.V., G.P., G.C., P.P., R.L., V.C., C.T.)
| | - M Hirano
- Department of Neurology (M.H.), Columbia University Medical Centre, New York, New York
| | - C Giordano
- Departments of Radiology, Oncology, and Pathology (A.P., C.G.)
| | - P Parchi
- Departments of Biomedical and Neuromotor Sciences (L.L.G., C.T., D.N.M., L.C., M.C., M.L.V., G.P., G.C., P.P., R.L., V.C., C.T.).,Istituto di Ricovero e Cura a Carattere Scientifico Institute of Neurological Sciences (L.C., M.C., M.L.V., G.P., P.P., V.C.), Bologna, Italy
| | - R Rinaldi
- Neurology Unit (R.D., R.R.), S.Orsola-Malpighi Hospital, Bologna, Italy
| | - R De Giorgio
- Surgical and Medical Sciences (E.B., F.G., L.P., R.D.G.), University of Bologna, Bologna, Italy
| | - R Lodi
- From the Functional MR Unit (L.L.G., C.T., D.N.M., R.L., C.T.) .,Departments of Biomedical and Neuromotor Sciences (L.L.G., C.T., D.N.M., L.C., M.C., M.L.V., G.P., G.C., P.P., R.L., V.C., C.T.)
| | - V Carelli
- Departments of Biomedical and Neuromotor Sciences (L.L.G., C.T., D.N.M., L.C., M.C., M.L.V., G.P., G.C., P.P., R.L., V.C., C.T.).,Istituto di Ricovero e Cura a Carattere Scientifico Institute of Neurological Sciences (L.C., M.C., M.L.V., G.P., P.P., V.C.), Bologna, Italy
| | - C Tonon
- From the Functional MR Unit (L.L.G., C.T., D.N.M., R.L., C.T.)
| |
Collapse
|